Amtech Esters IPO GMP

Listed

Amtech Esters IPO GMP & Listing Price

SME · ₹75 · 1600 shares/lot · BSE SME

Final GMP before listing
₹7+9.3%
▲ ₹9 since last reading
17 Sept, 3:36 pm
IST

Range so far: ₹5 low · ₹11 high

9 Sept17 Sept
Listed at
₹100
Listing gain / lot
+₹40,000
Cost / lot
₹1,20,000

GMP vs actual listing

GMP implied
+9.3%
Listed at
₹100
Actual
+33.3%

Closed its first day at ₹105 (+40.0% on the issue price)

Amtech Esters carried a grey market premium of ₹7 on an issue price of ₹75, implying a listing around ₹82 (+9.3%). It opened at ₹100, +33.3% — 24.0 points above what the grey market implied.

The premium shown is the one published here before listing, frozen at the bell and never revised afterwards. See all 208 calls, including the misses.

Timeline

  1. Opens
    9 Sept
  2. Closes
    11 Sept
  3. Allotment
    15 Sept
  4. Listing
    17 Sept

Subscription status

as of 17 Sept, 3:36 pm
Total25.7x
Issue typeSME
Incorporated2002
SectorSpecialty Chemicals
Price₹75
Lot size1600 shares
Min investment₹1,20,000
Issue size₹17.88 Cr
Face value₹10
RegistrarMaashitla Securities
ISININE0RMA01019
Listing atBSE SME
Listing dateThu, 17 Sept, 2026
BSE code544920

Not in our records for this issue: P/E ratio.

Official documents

Amtech Esters IPO FAQs

What was the listing price of Amtech Esters IPO?

Amtech Esters IPO listed at ₹100 on Thu, 17 Sept, 2026, +33.3% against the issue price of ₹75, a gain of ₹40,000 on one lot of 1600 shares. The last grey market premium before listing was ₹7, which implied ₹82.

What was the GMP of Amtech Esters IPO before listing?

The last grey market premium for Amtech Esters IPO was ₹7, recorded at 3:36 pm IST on Thu, 17 Sept, 2026. That implied +9.3% over the ₹75 price. The stock actually listed +33.3%, so GMP was off by 24.0%.

When was Amtech Esters IPO allotment and listing?

Allotment for Amtech Esters IPO was finalised on Tue, 15 Sept, 2026 and the shares listed on Thu, 17 Sept, 2026 on BSE SME. The registrar is Maashitla Securities.

GMP is unofficial. Grey market premium is an unregulated, over-the-counter indication with no backing from SEBI, BSE or NSE. It is not a listing-price guarantee and not investment advice. Read the RHP and consult a SEBI-registered adviser before applying.